Zydus and Beihai Biotech sign an exclusive licensing, supply and commercialization agreement for BEIZRAY (Albumin Solubilized Docetaxel Injection), a 505(B)(2) product for the US market
Ahmedabad, India and Zhuhai, China, February 14, 2025 Zydus Lifesciences Ltd., a global innovation driven healthcare company announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE has entered into […]
Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.0005 (0.05 mg/mL)
Mahwah, New Jersey, February 14, 2025 – Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the launch1 of Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL). Glenmark’s Latanoprost Ophthalmic Solution, 0.005% […]
